Evidence map›Paper›PMID 36727507›Full record

ArticleStroke2023

Smoking-Cessation Pharmacotherapy After Stroke and Transient Ischemic Attack: A Get With The Guidelines-Stroke Analysis.

Neal S Parikh, Cenai Zhang, Setareh Salehi Omran, Daniel Restifo, Matthew J Carpenter, Lee Schwamm, Hooman Kamel

Abstract readLetter
In one paragraph

Article in Stroke, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Impact of tobacco smoking on disease-specific outcomes in common neurological disorders: A scoping review.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2024
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Neal S ParikhClinical and Translational Neuroscience Unit, Weill Cornell Medicine, New York (N.S.P., C.Z., D.R., H.K.).ORCID 0000-0002-8802-2380
Cenai ZhangClinical and Translational Neuroscience Unit, Weill Cornell Medicine, New York (N.S.P., C.Z., D.R., H.K.).ORCID 0000-0001-8137-1644
Setareh Salehi OmranDepartment of Neurology, University of Colorado School of Medicine, Aurora (S.S.O.).ORCID 0000-0002-3184-5327
Daniel RestifoClinical and Translational Neuroscience Unit, Weill Cornell Medicine, New York (N.S.P., C.Z., D.R., H.K.).ORCID 0000-0003-1963-0742
Matthew J CarpenterDepartment of Psychiatry and Behavioral Sciences, Hollings Cancer Center, Medical University of South Carolina, Charleston (M.J.C.).ORCID 0000-0002-8909-1302
Lee SchwammDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (L.S.).ORCID 0000-0003-0592-9145
Hooman KamelClinical and Translational Neuroscience Unit, Weill Cornell Medicine, New York (N.S.P., C.Z., D.R., H.K.).ORCID 0000-0002-5745-0307

Funding

AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)U01NS095869 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BRODERICK, JOSEPH PAUL, KAMEL, HOOMAN · 2017 to 2022
$22.0M
New England Regional Coordinating Center for the NINDS Stroke Trials Network (StrokeNet)U24NS107243 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ANEESH B SINGHAL · 2018 to 2026
$3.3M
Role of Liver Fibrosis in Cognitive Impairment and DementiaK23AG073524 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI PARIKH, NEAL S · 2021 to 2023
$585k
NIA NIH HHS K23 AG073524NINDS NIH HHS U01 NS095869NINDS NIH HHS U24 NS107243
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ischemic Attack, TransientSmoking CessationStrokeHumansRisk FactorsSmokingcerebrovascular disorderssmoking cessationstroketransient ischemic attack

Identifiers

PMID36727507
PMCPMC9992306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.